TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Novo Nordisk Pharmatech A/S
Closing information (x1000 SEK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
895,294
|
851,405
|
900,923 |
| Earnings before taxes |
73,709
|
201,763
|
197,216 |
| Total assets |
1,446,971
|
880,067
|
1,005,889 |
| Current assets |
753,803
|
339,723
|
514,355 |
| Current liabilities |
350,523
|
124,515
|
146,555 |
| Equity capital |
1,032,003
|
715,479
|
818,222 |
| - share capital |
14,966
|
13,753
|
13,492 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
71.3%
|
81.3%
|
81.3% |
| Turnover per employee |
5,969
|
5,676
|
6,006 |
| Profit as a percentage of turnover |
8.2%
|
23.7%
|
21.9% |
| Return on assets (ROA) | |||
| Current ratio |
215.1%
|
272.8%
|
351.0% |
| Return on equity (ROE) |
7.1%
|
28.2%
|
24.1% |
| Change turnover |
-31,154
|
-66,901
|
63,059 |
| Change turnover % |
-3%
|
-7%
|
8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.